WATER versus WATER II 5‐year update: Comparing <scp>Aquablation</scp> therapy for benign prostatic hyperplasia in 30–80‐cm<sup>3</sup> and 80–150‐cm<sup>3</sup> prostates
The 5-year follow-up affirms that Aquablation therapy exhibits sustained outcomes, minimal irreversible complications, and low retreatment rates for treating LUTS/BPH, irrespective of prostate volume ranging from 30 to 150 cm<sup>3</sup>.
Authors
- Mihir Desai (ORCID: https://orcid.org/0000-0002-3744-8234)
- Paul Anderson (ORCID: https://orcid.org/0000-0003-3348-9597)
- Kevin C. Zorn (ORCID: https://orcid.org/0000-0003-3651-6669)
- Peter Gilling (ORCID: https://orcid.org/0000-0002-3118-1655)
- Gopal Badlani (ORCID: https://orcid.org/0000-0002-3158-8092)
- Naeem Bhojani (ORCID: https://orcid.org/0000-0003-2679-2635)
- Mohamad Baker Berjaoui (ORCID: https://orcid.org/0009-0005-9950-4608)
- Mitch Humphreys
- Steven A. Kaplan (ORCID: https://orcid.org/0000-0003-2558-7306)
- Dean Elterman (ORCID: https://orcid.org/0000-0003-1507-7783)
- David‐Dan Nguyen (ORCID: https://orcid.org/0000-0001-5570-8792)
- Karim Daher
- Neil Barber (ORCID: https://orcid.org/0009-0008-1448-8277)
- Saud Almousa
- Claus Roehrborn
- Mo Bidair
- Ronald P. Kaufman
Institutions
- University of Southern California (US)
- The Royal Melbourne Hospital (AU)
- University of Toronto (CA)
- Frimley Park Hospital (GB)
- WinnMed (US)
- Mount Sinai Hospital (US)
- Urology Bay of Plenty (NZ)
- Los Angeles Clinical Trials (US)
- Centre Hospitalier de l’Université de Montréal (CA)
- Mayo Clinic in Florida (US)
- Wake Forest University (US)
- Albany Medical Center Hospital (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- BJUI Compass
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1002/bco2.430
- Citations
- 10
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 5.35